Zydus Lifesciences announced that the safety and efficacy analysis data from the phase-III clinical trial of its Covid-19 vaccine ZyCoV-D has been examined and published...
Zydus Lifesciences said its subsidiary had acquired US-based BridgeBio Pharma. Sentynl Therapeutics, a subsidiary of Zydus Lifesciences and BridgeBio Pharma, have done an asset purchase...
Zydus Lifesciences announced that it had received approval from the Drug Controller General of India (DCGI) for Oxemia, an oral treatment for anaemia linked with...